Balaxi Pharma established a manufacturing facility, with operations expected to commence in H1 FY27. The company acquired Balaxi Healthcare Nicaragua as a wholly owned subsidiary and struck off its Centrafrique unit. It maintains its focus on 100% international wholesale pharmaceutical trading.